ABO-Incompatible Liver Transplantation under the Desensitization Protocol with Rituximab: Effect on Biliary Microbiota and Metabolites
Background: ABO-incompatible liver transplantation (ABOi LT) under the desensitization protocol with rituximab had excellent survival outcomes comparable to those of ABO-compatible liver transplantation (ABOc LT). In this work, we explored the effect of ABOi LT on recipients from the perspective of...
Main Authors: | Min Xiao, Zhenmiao Wan, Xin Lin, Di Wang, Zhitao Chen, Yangjun Gu, Songming Ding, Shusen Zheng, Qiyong Li |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/12/1/141 |
Similar Items
-
Rituximab and hypogammaglobulinemia in the setting of ABO-incompatible kidney transplantation
by: Hamza Naciri Bennani, et al.
Published: (2018-07-01) -
Laboratory support of ABO antibody monitoring for ABO-incompatible solid organ transplantation
by: Yousun Chung, et al.
Published: (2022-06-01) -
ABO-incompatible granulocyte transfusion: Is ABO subgroup a barrier?
by: Soma Agrawal, et al.
Published: (2022-01-01) -
SINGLE-CENTER EXPERIENCE OF ABO-INCOMPATIBLE LIVER TRANSPLANTATION
by: S. V. Gautier, et al.
Published: (2011-06-01) -
Changes in T Cells After ABO-Incompatible Liver Transplantation
by: Jong Man Kim, et al.
Published: (2017-07-01)